BioSpace News Archive

Policy

Polyganics Achieves CE Mark Certification for LIQOSEAL®

Polyganics announced that it has obtained CE marking for LIQOSEAL®, its easy-to-use and innovative dural sealant patch, and will launch the device in Europe with immediate effect.

January 8, 2020
·
5 min read
BioCapital

FARE, J&J Fund Research Grant to Discover Food Allergy Biomarkers

FARE said the biomarker research project, which will be conducted at Janssen’s World Without Disease Accelerator, “has the potential to make a real and significant impact for the 32 million Americans living with food allergies.”

January 8, 2020
·
2 min read
·
Alex Keown
Setting Yourself Up for a Promotion in 2020

If one of your goals is to go for that big promotion this year, there are a few things you can do now to get the ball rolling.

January 8, 2020
·
2 min read
·
Laura Brothers
Bio NC

What Does 2020 Have in Store for the Pharma Industry?

BioSpace spoke to leaders from various corners of the industry who provided their insights into what the coming year is likely to hold for their particular sphere.

January 8, 2020
·
4 min read
·
Alex Keown
China’s Adagene Snags $69 Million to Advance Cancer Pipeline

The funds will be used to support the development of its lead clinical assets under development as cancer treatments.

January 8, 2020
·
2 min read
·
Alex Keown
BioSpace Global Roundup, Jan. 9

Pharma and biotech companies from across the globe provide business and pipeline updates.

January 8, 2020
·
6 min read
·
Alex Keown
Business

Compugen Announces Appointment of Dr. Oliver Froescheis as Senior Vice President, Corporate and Business Development

Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced the appointment of Oliver Froescheis, Ph.D., as Senior Vice President, Corporate and Business Development.

January 8, 2020
·
5 min read
Business

Provention Bio Appoints Jason Hoitt as Chief Commercial Officer

Provention Bio, Inc. announced the appointment of Jason Hoitt as Chief Commercial Officer.

January 8, 2020
·
4 min read
Policy

Aruvant Receives FDA Rare Pediatric Disease Designation for ARU-1801 for the Treatment of Sickle Cell Disease

ARU-1801 is being developed as a potential one-time treatment for patients suffering from sickle cell disease and β-thalassemia

January 8, 2020
·
3 min read
Genetown

Checkmate Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference

Checkmate Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused upon activation of innate immunity to treat cancer, today announced that it will make a presentation at the 38th Annual J.P. Morgan Healthcare Conference.

January 8, 2020
·
1 min read